Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendations.

PropertyValue
has major subject area list Calcitonin Gene-Related Peptide Receptor Antagonists; Migraine Disorders
information resource reference Tepper SJ, Sheikh HU, Dougherty CO, Nahas SJ, Winner PK, Karanam AK, Blumenfeld AM, Abdrabboh A, Rasmussen S, Weiss JL, Ailani J. Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendations. Headache. 2022 04; 62(4):420-435.
label Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendations.

Search Criteria
  • Migraine

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)